Results 121 to 130 of about 15,631 (257)

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. [PDF]

open access: yes, 2014
BACKGROUND: Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations.
Agarwal   +163 more
core   +1 more source

Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature

open access: yesCase Reports in Nephrology and Dialysis
Introduction: Salbutamol is a moderately selective beta-2-adrenergic agonist. Various side effects can occur because of beta-1 and beta-2 receptor activation. Due to the large volume of distribution, it is not considered dialyzable.
Neva Bezeljak   +3 more
doaj   +1 more source

The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.

open access: yesJAMA Internal Medicine, 2015
IMPORTANCE The US Clean Air Act prohibits use of nonessential ozone-depleting substances. In 2005, the US Food and Drug Administration announced the ban of chlorofluorocarbon (CFC) albuterol inhalers by December 31, 2008.
A. Jena   +3 more
semanticscholar   +1 more source

Regular albuterol or nedocromil sodium — effects on airway subepithelial tenascin in asthma [PDF]

open access: yes, 1999
Both albuterol and nedocromil sodium have been recognized to possess certain anti-inflammatory properties. However, there are no data on the impact of these drugs on the pathophysiology of the bronchial extracellular matrix in asthma characterized by ...
Altraja, A.   +6 more
core   +1 more source

Nasal high-flow bronchodilator nebulization: a randomized cross-over study

open access: yesAnnals of Intensive Care, 2018
Background There is an absence of controlled clinical data showing bronchodilation effectiveness after nebulization via nasal high-flow therapy circuits. Results Twenty-five patients with reversible airflow obstruction received, in a randomized order: (1)
François Reminiac   +9 more
doaj   +1 more source

Inclusion Chromatography of Albuterol in Livestock by Nano-baskets [PDF]

open access: yes, 2012
Albuterol, which increases the muscle mass and decreases the adipose tissue, is misused as nutrient repartitioning agent in livestock. Hence, a new sensitive method for determination of albuterol in livestock is presented.
Mokhtari, B., Pourabdollah, K.
core  

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma

open access: yesCanadian Respiratory Journal, 2016
A reversibility test by an increase of greater than 12% in FEV1 can support a diagnosis of asthma and alter a patient’s treatment plan but may not be applicable to the young ages.
Daphna Vilozni   +5 more
doaj   +1 more source

Bronchial thermoplasty: implementing best practice in the era of cost containment. [PDF]

open access: yes, 2017
Increasing dependence on advanced technologies in the 21st century has created a dilemma between the practice and business of medicine. From information technology to robotic surgery, new technologies have expanded treatment possibilities and have ...
Kenyon, Nicholas   +3 more
core  

Evaluation of aerosolized medications during parabolic flight maneuvers [PDF]

open access: yes
The goal was to visually evaluate the effect gravity has on delivery of medications by the use of various aerosol devices. During parabolic flight the same four aerosols were retested as performed in studio ground tests.
Gosbee, John   +2 more
core   +1 more source

Phase 2 trial of montelukast for prevention of pain in sickle cell disease. [PDF]

open access: yes, 2020
Cysteinyl leukotrienes (CysLTs) are lipid mediators of inflammation. In patients with sickle cell disease (SCD), levels of CysLTs are increased compared with controls and associated with a higher rate of hospitalization for pain. We tested the hypothesis
Brandow, Amanda   +9 more
core  

Home - About - Disclaimer - Privacy